series-a
Stage
2020
Founded
3
Investors
About
City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi) therapeutics. It uses next-generation engineering of small interfering RNAs (siRNAs) to create medicines designed to silence gene expression and block protein production for treating various diseases.
Explore City Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.